Glucagon regulation of plasma ketone body concentration in human diabetes.

The present study was designed to test the hypothesis that physiological concentrations of glucagon may increase plasma ketone body concentration when sufficient free fatty acid substrate is available to support hepatic ketogenesis. Physiological elevations of plasma glucagon concentration were produced by a constant infusion of hormone, and increased plasma-free fatty acid availability was produced by simultaneous heparin injection to induce intravascular lipolysis. In the five insulin-dependent subjects studied, when plasma glucagon concentration remained at the normal basal level of 72+/-14 pg/ml during control saline infusion, the heparin-induced increase in free fatty acid availability resulted in approximately a 20% increase in plasma ketone body concentration. In contrast, when plasma glucagon concentration was elevated by hormone infusion to the physiological level of 215+/-35 pg/ml, the heparin-induced increases in free fatty acid availability resulted in approximately an 80% increase in plasma ketone body concentration. These results suggest that physiological elevations in plasma glucagon concentration may augment ketonemia in diabetic man when simultaneous elevations in plasma-free fatty acid arepresent.

[1]  R. Eaton,et al.  Modulation of Fatty Acid Metabolism by Glucagon in Man: IV. Effects of a Physiologic Hormone Infusion in Normal Man , 1976, Diabetes.

[2]  K. Alberti,et al.  ROLE OF GLUCAGON AND OTHER HORMONES IN DEVELOPMENT OF DIABETIC KETOACIDOSIS , 1975, The Lancet.

[3]  J. McGarry,et al.  Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. , 1975, The Journal of clinical investigation.

[4]  E. Tsalikian,et al.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. , 1975, The New England journal of medicine.

[5]  Eaton Rp,et al.  Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects. , 1975 .

[6]  E. Tsalikian,et al.  Plasma glucagon and alanine responses to acute insulin deficiency in man. , 1975, The Journal of clinical endocrinology and metabolism.

[7]  J. Gerich,et al.  Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. , 1974, The Journal of clinical investigation.

[8]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[9]  A K Bahn,et al.  Basic medical statistics. , 1973, Journal of the American Medical Women's Association.

[10]  J. McGarry,et al.  Regulation of ketogenesis and clinical aspects of the ketotic state. , 1972, Metabolism: clinical and experimental.

[11]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[12]  M. Heimberg,et al.  The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. , 1969, The Journal of biological chemistry.

[13]  P. Felig,et al.  Liver and kidney metabolism during prolonged starvation. , 1969, The Journal of clinical investigation.

[14]  R. Eaton,et al.  Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects. , 1975, Diabetes.

[15]  S. B. Lewis,et al.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. , 1974, The Journal of clinical investigation.